260 related articles for article (PubMed ID: 38666534)
21. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D
Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523
[TBL] [Abstract][Full Text] [Related]
22. Exosomal LncRNAs and hepatocellular Carcinoma: From basic research to clinical practice.
Li L; Bi Y; Diao S; Li X; Yuan T; Xu T; Huang C; Li J
Biochem Pharmacol; 2022 Jun; 200():115032. PubMed ID: 35395241
[TBL] [Abstract][Full Text] [Related]
23. Paradoxical functions of long noncoding RNAs in modulating STAT3 signaling pathway in hepatocellular carcinoma.
Mohan CD; Rangappa S; Nayak SC; Sethi G; Rangappa KS
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188574. PubMed ID: 34062154
[TBL] [Abstract][Full Text] [Related]
24. Silencing of long noncoding RNA HOXA11-AS inhibits the Wnt signaling pathway via the upregulation of HOXA11 and thereby inhibits the proliferation, invasion, and self-renewal of hepatocellular carcinoma stem cells.
Guo JC; Yang YJ; Zheng JF; Zhang JQ; Guo M; Yang X; Jiang XL; Xiang L; Li Y; Ping H; Zhuo L
Exp Mol Med; 2019 Nov; 51(11):1-20. PubMed ID: 31757938
[TBL] [Abstract][Full Text] [Related]
25. Long non‑coding RNAs in HBV‑related hepatocellular carcinoma (Review).
Zhang H; Chen X; Zhang J; Wang X; Chen H; Liu L; Liu S
Int J Oncol; 2020 Jan; 56(1):18-32. PubMed ID: 31746420
[TBL] [Abstract][Full Text] [Related]
26. LncRNA HClnc1 facilitates hepatocellular carcinoma progression by regulating PKM2 signaling and indicates poor survival outcome after hepatectomy.
Zhu Q; Lei Z; Xu C; Zhang Z; Yu Z; Cheng Z; Xiao P; Li S; Yu W; Zhou J
Cancer Med; 2023 Jul; 12(13):14526-14544. PubMed ID: 37212467
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNAs (lncRNAs) in hepatocellular carcinoma progression: Biological functions and new therapeutic targets.
Hashemi M; Mirzaei S; Zandieh MA; Rezaei S; Amirabbas Kakavand ; Dehghanpour A; Esmaeili N; Ghahremanzade A; Saebfar H; Heidari H; Salimimoghadam S; Taheriazam A; Entezari M; Ahn KS
Prog Biophys Mol Biol; 2023 Jan; 177():207-228. PubMed ID: 36584761
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
Qiu L; Tang Q; Li G; Chen K
Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
[TBL] [Abstract][Full Text] [Related]
29. The mRNA, miRNA and lncRNA networks in hepatocellular carcinoma: An integrative transcriptomic analysis from Gene Expression Omnibus.
Xu JH; Chang WH; Fu HW; Yuan T; Chen P
Mol Med Rep; 2018 May; 17(5):6472-6482. PubMed ID: 29512731
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanisms of circular RNAs, transforming growth factor-β, and long noncoding RNAs in hepatocellular carcinoma.
Shang W; Adzika GK; Li Y; Huang Q; Ding N; Chinembiri B; Rashid MS; Machuki JO
Cancer Med; 2019 Nov; 8(15):6684-6699. PubMed ID: 31523930
[TBL] [Abstract][Full Text] [Related]
31. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway.
Song W; Zhang J; Xia Q; Sun M
Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201
[No Abstract] [Full Text] [Related]
32. Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesis.
El Khodiry A; Afify M; El Tayebi HM
World J Gastroenterol; 2018 Feb; 24(5):549-572. PubMed ID: 29434445
[TBL] [Abstract][Full Text] [Related]
33. Progress and Prospects of Long Noncoding RNAs (lncRNAs) in Hepatocellular Carcinoma.
Li C; Chen J; Zhang K; Feng B; Wang R; Chen L
Cell Physiol Biochem; 2015; 36(2):423-34. PubMed ID: 25968300
[TBL] [Abstract][Full Text] [Related]
34. Differentially Expressed Long Noncoding RNAs Involved in FUBP1 Promoting Hepatocellular Carcinoma Cells Proliferation.
Li X; Yu H; Xu F; Wu Y; Sheng J
Biomed Res Int; 2021; 2021():6664519. PubMed ID: 33954195
[TBL] [Abstract][Full Text] [Related]
35. Circular RNA MAT2B Promotes Glycolysis and Malignancy of Hepatocellular Carcinoma Through the miR-338-3p/PKM2 Axis Under Hypoxic Stress.
Li Q; Pan X; Zhu D; Deng Z; Jiang R; Wang X
Hepatology; 2019 Oct; 70(4):1298-1316. PubMed ID: 31004447
[TBL] [Abstract][Full Text] [Related]
36. Functional roles of lncRNA-TUG1 in hepatocellular carcinoma.
Farzaneh M; Ghasemian M; Ghaedrahmati F; Poodineh J; Najafi S; Masoodi T; Kurniawan D; Uddin S; Azizidoost S
Life Sci; 2022 Nov; 308():120974. PubMed ID: 36126725
[TBL] [Abstract][Full Text] [Related]
37. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
39. Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway.
Xu M; Zhou C; Weng J; Chen Z; Zhou Q; Gao J; Shi G; Ke A; Ren N; Sun H; Shen Y
J Exp Clin Cancer Res; 2022 Aug; 41(1):253. PubMed ID: 35986343
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]